This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Dr. Adinarayana Kunamneni, PhD
Associate Professor of Medicine at Mayo Clinic
Speaker

Profile

Dr. Adinarayana Kunamneni received his Ph.D. degree in Pharmaceutical Sciences from the Andhra University, Visakhapatnam, India. After his Ph.D., he spent his postdoctoral years at CSIC (Spain), University of Kentucky (USA), and New Mexico VA Health Care System (USA). Kunamneni has over 20 years of research experience in pharmaceutical sciences in both academia and industry. His broad and in-depth knowledge & experience covers cellular / molecular biology, infectious diseases and molecular virology, viral / tumor immunology, molecular neuroscience and immunotherapy, and early phase drug discovery of bio-therapeutics, with special expertise in the discovery of therapeutic modalities based on therapeutic Abs (scFvs, mAbs, BsAbs, ADCs, etc). His research lab has been developing various engineered antibodies for various indications including chronic pain, stroke, cancer and many more. This work has been patented and supported by government grants, including NIH, VA and DoD mechanisms. Kunamneni has contributed to over 65 publications including book chapters, and 10 patents, earning more than 6,000 citations.

Agenda Sessions

  • Humanized scFv Antibody Specific to an Extracellular Epitope of P2X4R as Therapy for Chronic Pain Management

    15:15